nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—larynx—sarcoma	0.0335	0.119	CbGeAlD
Fludarabine—POLA1—mammary gland—sarcoma	0.0137	0.0486	CbGeAlD
Fludarabine—Adenosine monophosphate—CREB1—sarcoma	0.011	0.712	CrCbGaD
Fludarabine—RRM1—mammary gland—sarcoma	0.0109	0.0385	CbGeAlD
Fludarabine—POLA1—Vinblastine—Vincristine—sarcoma	0.00983	0.624	CbGdCrCtD
Fludarabine—POLA1—myometrium—sarcoma	0.0097	0.0345	CbGeAlD
Fludarabine—SLC29A1—mammary gland—sarcoma	0.00883	0.0313	CbGeAlD
Fludarabine—POLA1—seminal vesicle—sarcoma	0.00877	0.0311	CbGeAlD
Fludarabine—POLA1—hematopoietic system—sarcoma	0.00833	0.0296	CbGeAlD
Fludarabine—RRM1—myometrium—sarcoma	0.0077	0.0273	CbGeAlD
Fludarabine—SLC28A3—bone marrow—sarcoma	0.0076	0.027	CbGeAlD
Fludarabine—RRM1—seminal vesicle—sarcoma	0.00696	0.0247	CbGeAlD
Fludarabine—RRM1—hematopoietic system—sarcoma	0.00661	0.0235	CbGeAlD
Fludarabine—SLC29A1—myometrium—sarcoma	0.00626	0.0222	CbGeAlD
Fludarabine—DCK—myometrium—sarcoma	0.00598	0.0212	CbGeAlD
Fludarabine—RRM1—smooth muscle tissue—sarcoma	0.00582	0.0207	CbGeAlD
Fludarabine—DCK—embryo—sarcoma	0.00575	0.0204	CbGeAlD
Fludarabine—RRM1—skin of body—sarcoma	0.00575	0.0204	CbGeAlD
Fludarabine—POLA1—tendon—sarcoma	0.00551	0.0196	CbGeAlD
Fludarabine—DCK—seminal vesicle—sarcoma	0.0054	0.0192	CbGeAlD
Fludarabine—SLC29A1—hematopoietic system—sarcoma	0.00538	0.0191	CbGeAlD
Fludarabine—POLA1—bone marrow—sarcoma	0.00534	0.019	CbGeAlD
Fludarabine—SLC29A1—connective tissue—sarcoma	0.00518	0.0184	CbGeAlD
Fludarabine—DCK—hematopoietic system—sarcoma	0.00514	0.0182	CbGeAlD
Fludarabine—RRM1—cardiac atrium—sarcoma	0.00502	0.0178	CbGeAlD
Fludarabine—RRM1—uterus—sarcoma	0.005	0.0177	CbGeAlD
Fludarabine—RRM1—lymphoid tissue—sarcoma	0.00466	0.0165	CbGeAlD
Fludarabine—POLA1—testis—sarcoma	0.00457	0.0162	CbGeAlD
Fludarabine—Adenosine monophosphate—SRC—sarcoma	0.00443	0.288	CrCbGaD
Fludarabine—RRM1—tendon—sarcoma	0.00438	0.0155	CbGeAlD
Fludarabine—POLA1—liver—sarcoma	0.00432	0.0153	CbGeAlD
Fludarabine—RRM1—bone marrow—sarcoma	0.00424	0.0151	CbGeAlD
Fludarabine—SLC29A1—cardiac atrium—sarcoma	0.00408	0.0145	CbGeAlD
Fludarabine—SLC29A1—uterus—sarcoma	0.00406	0.0144	CbGeAlD
Fludarabine—DCK—cardiac atrium—sarcoma	0.0039	0.0138	CbGeAlD
Fludarabine—DCK—uterus—sarcoma	0.00388	0.0138	CbGeAlD
Fludarabine—SLC29A1—lymphoid tissue—sarcoma	0.00379	0.0134	CbGeAlD
Fludarabine—RRM1—testis—sarcoma	0.00362	0.0129	CbGeAlD
Fludarabine—DCK—lymphoid tissue—sarcoma	0.00362	0.0128	CbGeAlD
Fludarabine—SLC29A1—tendon—sarcoma	0.00356	0.0126	CbGeAlD
Fludarabine—SLC29A1—bone marrow—sarcoma	0.00345	0.0122	CbGeAlD
Fludarabine—RRM1—liver—sarcoma	0.00343	0.0122	CbGeAlD
Fludarabine—DCK—tendon—sarcoma	0.0034	0.0121	CbGeAlD
Fludarabine—POLA1—lymph node—sarcoma	0.00331	0.0118	CbGeAlD
Fludarabine—DCK—bone marrow—sarcoma	0.00329	0.0117	CbGeAlD
Fludarabine—DCK—Doxorubicin—Epirubicin—sarcoma	0.00307	0.195	CbGdCrCtD
Fludarabine—SLC29A1—testis—sarcoma	0.00295	0.0105	CbGeAlD
Fludarabine—DCK—Epirubicin—Doxorubicin—sarcoma	0.00284	0.181	CbGdCrCtD
Fludarabine—DCK—testis—sarcoma	0.00281	0.01	CbGeAlD
Fludarabine—SLC29A1—liver—sarcoma	0.00279	0.00989	CbGeAlD
Fludarabine—DCK—liver—sarcoma	0.00266	0.00945	CbGeAlD
Fludarabine—RRM1—lymph node—sarcoma	0.00263	0.00933	CbGeAlD
Fludarabine—SLC29A1—lymph node—sarcoma	0.00214	0.00758	CbGeAlD
Fludarabine—DCK—lymph node—sarcoma	0.00204	0.00725	CbGeAlD
Fludarabine—Infection—Vincristine—sarcoma	0.00093	0.00135	CcSEcCtD
Fludarabine—Dyspepsia—Thiotepa—sarcoma	0.00093	0.00135	CcSEcCtD
Fludarabine—Phlebitis—Doxorubicin—sarcoma	0.000929	0.00135	CcSEcCtD
Fludarabine—Confusional state—Mitoxantrone—sarcoma	0.00092	0.00134	CcSEcCtD
Fludarabine—Nervous system disorder—Vincristine—sarcoma	0.000918	0.00134	CcSEcCtD
Fludarabine—Decreased appetite—Thiotepa—sarcoma	0.000918	0.00134	CcSEcCtD
Fludarabine—Thrombocytopenia—Vincristine—sarcoma	0.000917	0.00133	CcSEcCtD
Fludarabine—Oedema—Mitoxantrone—sarcoma	0.000912	0.00133	CcSEcCtD
Fludarabine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000912	0.00133	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000912	0.00133	CcSEcCtD
Fludarabine—Decreased appetite—Dactinomycin—sarcoma	0.000911	0.00133	CcSEcCtD
Fludarabine—Fatigue—Thiotepa—sarcoma	0.00091	0.00132	CcSEcCtD
Fludarabine—Infection—Mitoxantrone—sarcoma	0.000906	0.00132	CcSEcCtD
Fludarabine—Hyperhidrosis—Vincristine—sarcoma	0.000905	0.00132	CcSEcCtD
Fludarabine—Fatigue—Dactinomycin—sarcoma	0.000904	0.00131	CcSEcCtD
Fludarabine—Pain—Thiotepa—sarcoma	0.000903	0.00131	CcSEcCtD
Fludarabine—Constipation—Thiotepa—sarcoma	0.000903	0.00131	CcSEcCtD
Fludarabine—Pain—Dactinomycin—sarcoma	0.000896	0.0013	CcSEcCtD
Fludarabine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000893	0.0013	CcSEcCtD
Fludarabine—Anorexia—Vincristine—sarcoma	0.000893	0.0013	CcSEcCtD
Fludarabine—Hepatic failure—Doxorubicin—sarcoma	0.000891	0.0013	CcSEcCtD
Fludarabine—Cardiac failure—Epirubicin—sarcoma	0.000886	0.00129	CcSEcCtD
Fludarabine—Cerebrovascular accident—Epirubicin—sarcoma	0.000883	0.00128	CcSEcCtD
Fludarabine—Cardiac failure congestive—Doxorubicin—sarcoma	0.000883	0.00128	CcSEcCtD
Fludarabine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000882	0.00128	CcSEcCtD
Fludarabine—Feeling abnormal—Thiotepa—sarcoma	0.00087	0.00127	CcSEcCtD
Fludarabine—Anorexia—Mitoxantrone—sarcoma	0.000869	0.00126	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000865	0.00126	CcSEcCtD
Fludarabine—Feeling abnormal—Dactinomycin—sarcoma	0.000864	0.00126	CcSEcCtD
Fludarabine—Ill-defined disorder—Etoposide—sarcoma	0.000862	0.00125	CcSEcCtD
Fludarabine—Anaemia—Etoposide—sarcoma	0.000859	0.00125	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000853	0.00124	CcSEcCtD
Fludarabine—Paraesthesia—Vincristine—sarcoma	0.000841	0.00122	CcSEcCtD
Fludarabine—Malaise—Etoposide—sarcoma	0.000838	0.00122	CcSEcCtD
Fludarabine—Body temperature increased—Thiotepa—sarcoma	0.000835	0.00121	CcSEcCtD
Fludarabine—Leukopenia—Etoposide—sarcoma	0.000832	0.00121	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000831	0.00121	CcSEcCtD
Fludarabine—Body temperature increased—Dactinomycin—sarcoma	0.000829	0.00121	CcSEcCtD
Fludarabine—Cardiac failure—Doxorubicin—sarcoma	0.00082	0.00119	CcSEcCtD
Fludarabine—Paraesthesia—Mitoxantrone—sarcoma	0.000819	0.00119	CcSEcCtD
Fludarabine—Cerebrovascular accident—Doxorubicin—sarcoma	0.000817	0.00119	CcSEcCtD
Fludarabine—Decreased appetite—Vincristine—sarcoma	0.000814	0.00118	CcSEcCtD
Fludarabine—Dyspnoea—Mitoxantrone—sarcoma	0.000813	0.00118	CcSEcCtD
Fludarabine—Cough—Etoposide—sarcoma	0.000811	0.00118	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Vincristine—sarcoma	0.000808	0.00118	CcSEcCtD
Fludarabine—Fatigue—Vincristine—sarcoma	0.000807	0.00117	CcSEcCtD
Fludarabine—Convulsion—Etoposide—sarcoma	0.000805	0.00117	CcSEcCtD
Fludarabine—Dehydration—Epirubicin—sarcoma	0.000805	0.00117	CcSEcCtD
Fludarabine—Dyspepsia—Mitoxantrone—sarcoma	0.000803	0.00117	CcSEcCtD
Fludarabine—Pain—Vincristine—sarcoma	0.000801	0.00117	CcSEcCtD
Fludarabine—Constipation—Vincristine—sarcoma	0.000801	0.00117	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000801	0.00116	CcSEcCtD
Fludarabine—Liver function test abnormal—Epirubicin—sarcoma	0.000799	0.00116	CcSEcCtD
Fludarabine—Decreased appetite—Mitoxantrone—sarcoma	0.000793	0.00115	CcSEcCtD
Fludarabine—Fatigue—Mitoxantrone—sarcoma	0.000786	0.00114	CcSEcCtD
Fludarabine—Discomfort—Etoposide—sarcoma	0.000782	0.00114	CcSEcCtD
Fludarabine—Constipation—Mitoxantrone—sarcoma	0.00078	0.00113	CcSEcCtD
Fludarabine—Pain—Mitoxantrone—sarcoma	0.00078	0.00113	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000779	0.00113	CcSEcCtD
Fludarabine—Hypersensitivity—Thiotepa—sarcoma	0.000778	0.00113	CcSEcCtD
Fludarabine—Hypersensitivity—Dactinomycin—sarcoma	0.000772	0.00112	CcSEcCtD
Fludarabine—Confusional state—Etoposide—sarcoma	0.000765	0.00111	CcSEcCtD
Fludarabine—Anaphylactic shock—Etoposide—sarcoma	0.000759	0.0011	CcSEcCtD
Fludarabine—Asthenia—Thiotepa—sarcoma	0.000758	0.0011	CcSEcCtD
Fludarabine—Infection—Etoposide—sarcoma	0.000754	0.0011	CcSEcCtD
Fludarabine—Asthenia—Dactinomycin—sarcoma	0.000752	0.00109	CcSEcCtD
Fludarabine—Feeling abnormal—Mitoxantrone—sarcoma	0.000752	0.00109	CcSEcCtD
Fludarabine—Dysphagia—Epirubicin—sarcoma	0.000748	0.00109	CcSEcCtD
Fludarabine—Pruritus—Thiotepa—sarcoma	0.000747	0.00109	CcSEcCtD
Fludarabine—Dehydration—Doxorubicin—sarcoma	0.000744	0.00108	CcSEcCtD
Fludarabine—Thrombocytopenia—Etoposide—sarcoma	0.000743	0.00108	CcSEcCtD
Fludarabine—Body temperature increased—Vincristine—sarcoma	0.00074	0.00108	CcSEcCtD
Fludarabine—Liver function test abnormal—Doxorubicin—sarcoma	0.000739	0.00108	CcSEcCtD
Fludarabine—Hyperhidrosis—Etoposide—sarcoma	0.000733	0.00107	CcSEcCtD
Fludarabine—Angina pectoris—Epirubicin—sarcoma	0.000728	0.00106	CcSEcCtD
Fludarabine—Anorexia—Etoposide—sarcoma	0.000723	0.00105	CcSEcCtD
Fludarabine—Diarrhoea—Thiotepa—sarcoma	0.000723	0.00105	CcSEcCtD
Fludarabine—Body temperature increased—Mitoxantrone—sarcoma	0.000721	0.00105	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000721	0.00105	CcSEcCtD
Fludarabine—Bronchitis—Epirubicin—sarcoma	0.000719	0.00105	CcSEcCtD
Fludarabine—Diarrhoea—Dactinomycin—sarcoma	0.000717	0.00104	CcSEcCtD
Fludarabine—Pancytopenia—Epirubicin—sarcoma	0.00071	0.00103	CcSEcCtD
Fludarabine—Neutropenia—Epirubicin—sarcoma	0.000699	0.00102	CcSEcCtD
Fludarabine—Dysuria—Epirubicin—sarcoma	0.000699	0.00102	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000695	0.00101	CcSEcCtD
Fludarabine—Dysphagia—Doxorubicin—sarcoma	0.000692	0.00101	CcSEcCtD
Fludarabine—Hypersensitivity—Vincristine—sarcoma	0.00069	0.001	CcSEcCtD
Fludarabine—Paraesthesia—Etoposide—sarcoma	0.000681	0.000991	CcSEcCtD
Fludarabine—Dyspnoea—Etoposide—sarcoma	0.000676	0.000984	CcSEcCtD
Fludarabine—Hyperglycaemia—Epirubicin—sarcoma	0.000675	0.000981	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—sarcoma	0.000674	0.000981	CcSEcCtD
Fludarabine—Hypersensitivity—Mitoxantrone—sarcoma	0.000672	0.000978	CcSEcCtD
Fludarabine—Asthenia—Vincristine—sarcoma	0.000672	0.000978	CcSEcCtD
Fludarabine—Vomiting—Thiotepa—sarcoma	0.000671	0.000977	CcSEcCtD
Fludarabine—Pneumonia—Epirubicin—sarcoma	0.000671	0.000976	CcSEcCtD
Fludarabine—Vomiting—Dactinomycin—sarcoma	0.000666	0.00097	CcSEcCtD
Fludarabine—Rash—Thiotepa—sarcoma	0.000666	0.000969	CcSEcCtD
Fludarabine—Bronchitis—Doxorubicin—sarcoma	0.000665	0.000968	CcSEcCtD
Fludarabine—Dermatitis—Thiotepa—sarcoma	0.000665	0.000968	CcSEcCtD
Fludarabine—Headache—Thiotepa—sarcoma	0.000662	0.000963	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000661	0.000962	CcSEcCtD
Fludarabine—Rash—Dactinomycin—sarcoma	0.000661	0.000962	CcSEcCtD
Fludarabine—Decreased appetite—Etoposide—sarcoma	0.000659	0.00096	CcSEcCtD
Fludarabine—Pancytopenia—Doxorubicin—sarcoma	0.000657	0.000956	CcSEcCtD
Fludarabine—Renal failure—Epirubicin—sarcoma	0.000655	0.000954	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Etoposide—sarcoma	0.000655	0.000953	CcSEcCtD
Fludarabine—Asthenia—Mitoxantrone—sarcoma	0.000654	0.000952	CcSEcCtD
Fludarabine—Fatigue—Etoposide—sarcoma	0.000654	0.000952	CcSEcCtD
Fludarabine—Neuropathy peripheral—Epirubicin—sarcoma	0.000654	0.000951	CcSEcCtD
Fludarabine—Stomatitis—Epirubicin—sarcoma	0.00065	0.000946	CcSEcCtD
Fludarabine—Constipation—Etoposide—sarcoma	0.000649	0.000944	CcSEcCtD
Fludarabine—Pain—Etoposide—sarcoma	0.000649	0.000944	CcSEcCtD
Fludarabine—Urinary tract infection—Epirubicin—sarcoma	0.000648	0.000943	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—sarcoma	0.000647	0.000941	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—sarcoma	0.000647	0.000941	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000643	0.000936	CcSEcCtD
Fludarabine—Diarrhoea—Vincristine—sarcoma	0.000641	0.000932	CcSEcCtD
Fludarabine—Haematuria—Epirubicin—sarcoma	0.000636	0.000925	CcSEcCtD
Fludarabine—Epistaxis—Epirubicin—sarcoma	0.000629	0.000915	CcSEcCtD
Fludarabine—Nausea—Thiotepa—sarcoma	0.000627	0.000913	CcSEcCtD
Fludarabine—Sinusitis—Epirubicin—sarcoma	0.000625	0.00091	CcSEcCtD
Fludarabine—Feeling abnormal—Etoposide—sarcoma	0.000625	0.00091	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—sarcoma	0.000624	0.000908	CcSEcCtD
Fludarabine—Diarrhoea—Mitoxantrone—sarcoma	0.000624	0.000908	CcSEcCtD
Fludarabine—Nausea—Dactinomycin—sarcoma	0.000623	0.000906	CcSEcCtD
Fludarabine—Pneumonia—Doxorubicin—sarcoma	0.00062	0.000903	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000612	0.00089	CcSEcCtD
Fludarabine—Renal failure—Doxorubicin—sarcoma	0.000606	0.000882	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000605	0.00088	CcSEcCtD
Fludarabine—Haemoglobin—Epirubicin—sarcoma	0.000602	0.000875	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—sarcoma	0.000601	0.000875	CcSEcCtD
Fludarabine—Body temperature increased—Etoposide—sarcoma	0.0006	0.000873	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—sarcoma	0.0006	0.000873	CcSEcCtD
Fludarabine—Haemorrhage—Epirubicin—sarcoma	0.000599	0.000871	CcSEcCtD
Fludarabine—Hypoaesthesia—Epirubicin—sarcoma	0.000596	0.000867	CcSEcCtD
Fludarabine—Vomiting—Vincristine—sarcoma	0.000595	0.000866	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—sarcoma	0.000594	0.000864	CcSEcCtD
Fludarabine—Rash—Vincristine—sarcoma	0.00059	0.000859	CcSEcCtD
Fludarabine—Dermatitis—Vincristine—sarcoma	0.00059	0.000858	CcSEcCtD
Fludarabine—Haematuria—Doxorubicin—sarcoma	0.000588	0.000856	CcSEcCtD
Fludarabine—Headache—Vincristine—sarcoma	0.000587	0.000854	CcSEcCtD
Fludarabine—Epistaxis—Doxorubicin—sarcoma	0.000582	0.000847	CcSEcCtD
Fludarabine—Vomiting—Mitoxantrone—sarcoma	0.00058	0.000844	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—sarcoma	0.000579	0.000842	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—sarcoma	0.000577	0.000839	CcSEcCtD
Fludarabine—Rash—Mitoxantrone—sarcoma	0.000575	0.000837	CcSEcCtD
Fludarabine—Dermatitis—Mitoxantrone—sarcoma	0.000574	0.000836	CcSEcCtD
Fludarabine—Headache—Mitoxantrone—sarcoma	0.000571	0.000831	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—sarcoma	0.000566	0.000823	CcSEcCtD
Fludarabine—Hypersensitivity—Etoposide—sarcoma	0.000559	0.000813	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—sarcoma	0.000557	0.00081	CcSEcCtD
Fludarabine—Nausea—Vincristine—sarcoma	0.000556	0.000809	CcSEcCtD
Fludarabine—Haemorrhage—Doxorubicin—sarcoma	0.000554	0.000806	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—sarcoma	0.000551	0.000802	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—sarcoma	0.00055	0.0008	CcSEcCtD
Fludarabine—Asthenia—Etoposide—sarcoma	0.000544	0.000792	CcSEcCtD
Fludarabine—Nausea—Mitoxantrone—sarcoma	0.000542	0.000788	CcSEcCtD
Fludarabine—Chills—Epirubicin—sarcoma	0.000537	0.000781	CcSEcCtD
Fludarabine—Pruritus—Etoposide—sarcoma	0.000537	0.000781	CcSEcCtD
Fludarabine—Arrhythmia—Epirubicin—sarcoma	0.000535	0.000778	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—sarcoma	0.000534	0.000777	CcSEcCtD
Fludarabine—Alopecia—Epirubicin—sarcoma	0.000529	0.00077	CcSEcCtD
Fludarabine—Erythema multiforme—Doxorubicin—sarcoma	0.000524	0.000762	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—sarcoma	0.000521	0.000758	CcSEcCtD
Fludarabine—Diarrhoea—Etoposide—sarcoma	0.000519	0.000755	CcSEcCtD
Fludarabine—Chills—Doxorubicin—sarcoma	0.000497	0.000723	CcSEcCtD
Fludarabine—Arrhythmia—Doxorubicin—sarcoma	0.000495	0.00072	CcSEcCtD
Fludarabine—Alopecia—Doxorubicin—sarcoma	0.000489	0.000712	CcSEcCtD
Fludarabine—Ill-defined disorder—Epirubicin—sarcoma	0.000483	0.000703	CcSEcCtD
Fludarabine—Vomiting—Etoposide—sarcoma	0.000482	0.000702	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—sarcoma	0.000482	0.000701	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—sarcoma	0.000482	0.000701	CcSEcCtD
Fludarabine—Agitation—Epirubicin—sarcoma	0.000479	0.000697	CcSEcCtD
Fludarabine—Rash—Etoposide—sarcoma	0.000478	0.000696	CcSEcCtD
Fludarabine—Dermatitis—Etoposide—sarcoma	0.000478	0.000695	CcSEcCtD
Fludarabine—Headache—Etoposide—sarcoma	0.000475	0.000691	CcSEcCtD
Fludarabine—Malaise—Epirubicin—sarcoma	0.00047	0.000684	CcSEcCtD
Fludarabine—Leukopenia—Epirubicin—sarcoma	0.000466	0.000679	CcSEcCtD
Fludarabine—Cough—Epirubicin—sarcoma	0.000455	0.000662	CcSEcCtD
Fludarabine—Convulsion—Epirubicin—sarcoma	0.000451	0.000657	CcSEcCtD
Fludarabine—Nausea—Etoposide—sarcoma	0.000451	0.000656	CcSEcCtD
Fludarabine—Ill-defined disorder—Doxorubicin—sarcoma	0.000447	0.000651	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—sarcoma	0.000446	0.000648	CcSEcCtD
Fludarabine—Myalgia—Epirubicin—sarcoma	0.000444	0.000645	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—sarcoma	0.000444	0.000645	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—sarcoma	0.000443	0.000645	CcSEcCtD
Fludarabine—Discomfort—Epirubicin—sarcoma	0.000438	0.000638	CcSEcCtD
Fludarabine—Malaise—Doxorubicin—sarcoma	0.000435	0.000633	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—sarcoma	0.000432	0.000628	CcSEcCtD
Fludarabine—Confusional state—Epirubicin—sarcoma	0.000429	0.000624	CcSEcCtD
Fludarabine—Anaphylactic shock—Epirubicin—sarcoma	0.000425	0.000619	CcSEcCtD
Fludarabine—Oedema—Epirubicin—sarcoma	0.000425	0.000619	CcSEcCtD
Fludarabine—Infection—Epirubicin—sarcoma	0.000422	0.000615	CcSEcCtD
Fludarabine—Cough—Doxorubicin—sarcoma	0.000421	0.000612	CcSEcCtD
Fludarabine—Convulsion—Doxorubicin—sarcoma	0.000418	0.000608	CcSEcCtD
Fludarabine—Nervous system disorder—Epirubicin—sarcoma	0.000417	0.000607	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—sarcoma	0.000416	0.000606	CcSEcCtD
Fludarabine—Hyperhidrosis—Epirubicin—sarcoma	0.000411	0.000598	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—sarcoma	0.00041	0.000597	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—sarcoma	0.00041	0.000597	CcSEcCtD
Fludarabine—Discomfort—Doxorubicin—sarcoma	0.000406	0.00059	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—sarcoma	0.000405	0.00059	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—sarcoma	0.000397	0.000577	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—sarcoma	0.000393	0.000572	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—sarcoma	0.000393	0.000572	CcSEcCtD
Fludarabine—Infection—Doxorubicin—sarcoma	0.000391	0.000569	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000387	0.000564	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—sarcoma	0.000386	0.000561	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—sarcoma	0.000385	0.000561	CcSEcCtD
Fludarabine—Paraesthesia—Epirubicin—sarcoma	0.000382	0.000556	CcSEcCtD
Fludarabine—Hyperhidrosis—Doxorubicin—sarcoma	0.00038	0.000553	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—sarcoma	0.000379	0.000552	CcSEcCtD
Fludarabine—Anorexia—Doxorubicin—sarcoma	0.000375	0.000546	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—sarcoma	0.000374	0.000545	CcSEcCtD
Fludarabine—Decreased appetite—Epirubicin—sarcoma	0.00037	0.000538	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000367	0.000534	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—sarcoma	0.000367	0.000533	CcSEcCtD
Fludarabine—Constipation—Epirubicin—sarcoma	0.000364	0.000529	CcSEcCtD
Fludarabine—Pain—Epirubicin—sarcoma	0.000364	0.000529	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000358	0.000522	CcSEcCtD
Fludarabine—Paraesthesia—Doxorubicin—sarcoma	0.000353	0.000514	CcSEcCtD
Fludarabine—Dyspnoea—Doxorubicin—sarcoma	0.000351	0.00051	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—sarcoma	0.00035	0.00051	CcSEcCtD
Fludarabine—Dyspepsia—Doxorubicin—sarcoma	0.000346	0.000504	CcSEcCtD
Fludarabine—Decreased appetite—Doxorubicin—sarcoma	0.000342	0.000498	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00034	0.000494	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—sarcoma	0.000339	0.000494	CcSEcCtD
Fludarabine—Pain—Doxorubicin—sarcoma	0.000336	0.00049	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—sarcoma	0.000336	0.00049	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—sarcoma	0.000336	0.000489	CcSEcCtD
Fludarabine—Feeling abnormal—Doxorubicin—sarcoma	0.000324	0.000472	CcSEcCtD
Fludarabine—Hypersensitivity—Epirubicin—sarcoma	0.000313	0.000456	CcSEcCtD
Fludarabine—Body temperature increased—Doxorubicin—sarcoma	0.000311	0.000453	CcSEcCtD
Fludarabine—Asthenia—Epirubicin—sarcoma	0.000305	0.000444	CcSEcCtD
Fludarabine—Pruritus—Epirubicin—sarcoma	0.000301	0.000438	CcSEcCtD
Fludarabine—Diarrhoea—Epirubicin—sarcoma	0.000291	0.000423	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—sarcoma	0.00029	0.000422	CcSEcCtD
Fludarabine—Asthenia—Doxorubicin—sarcoma	0.000282	0.000411	CcSEcCtD
Fludarabine—Pruritus—Doxorubicin—sarcoma	0.000278	0.000405	CcSEcCtD
Fludarabine—Vomiting—Epirubicin—sarcoma	0.00027	0.000393	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—sarcoma	0.000269	0.000392	CcSEcCtD
Fludarabine—Rash—Epirubicin—sarcoma	0.000268	0.00039	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—sarcoma	0.000268	0.00039	CcSEcCtD
Fludarabine—Headache—Epirubicin—sarcoma	0.000266	0.000388	CcSEcCtD
Fludarabine—Nausea—Epirubicin—sarcoma	0.000253	0.000368	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—sarcoma	0.00025	0.000364	CcSEcCtD
Fludarabine—Rash—Doxorubicin—sarcoma	0.000248	0.000361	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—sarcoma	0.000248	0.000361	CcSEcCtD
Fludarabine—Headache—Doxorubicin—sarcoma	0.000246	0.000359	CcSEcCtD
Fludarabine—Nausea—Doxorubicin—sarcoma	0.000234	0.00034	CcSEcCtD
